First-in-human study of PC14586, a small molecule structural corrector of Y220C mutant p53, in patients with advanced solid tumors harboring a TP53 Y220C mutation Meeting Abstract
| Authors: | Dumbrava, E. E.; Johnson, M. L.; Tolcher, A. W.; Shapiro, G.; Thompson, J. A.; El-Khoueiry, A. B.; Vandross, A. L.; Kummar, S.; Parikh, A. R.; Munster, P. N.; Daly, E.; De Leon, L.; Khaddar, M.; LeDuke, K.; Robell, K.; Sheehan, L. I.; St Louis, M.; Wiebesiek, A.; Alland, L.; Schram, A. M. |
| Abstract Title: | First-in-human study of PC14586, a small molecule structural corrector of Y220C mutant p53, in patients with advanced solid tumors harboring a TP53 Y220C mutation |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300896 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.3003 |
| Notes: | Meeting Abstract: 3003 -- This meeting was also held virtually -- Source: Wos |
